Wanda J. Torres
FDA investigator
Appears on 1 document from 2000, mostly at sites in Maryland. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 11.0
- Observations per 483
- 2000
- First seen
- 2000
- Most recent
What they cite most
From 11 observations- 21 CFR 211.160General requirements5
- 21 CFR 211.192Production record review5
- 21 CFR 211.100Written procedures; deviations2
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.84Testing and approval or rejection of components, drug product containers, and closures1
Activity by year
2000: 1
Where
Maryland 1
Often inspects with
Is Wanda J. Torres coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2000-12-14 | 483 Schering-Plough Products, LLCDec 14, 2000 · Manati, Maryland | Manati, Maryland | 11 |
About this profile
What does Wanda J. Torres inspect?
Wanda J. Torres appears on 1 document on file covering 1 site, mostly in Maryland.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.100.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Wanda J. Torres is dated Dec 14, 2000.